Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.pspprojects.com | |
Market Cap | 2,791.26 Cr. | |
Enterprise Value(EV) | 2,944.45 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 43.81 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 17.70 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 85.15 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 241.22 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.21 | Calculated using Price: 775.35 |
Dividend Yield | 0.32 | Period Ending 2023-03 |
No. of Shares Subscribed | 3.60 Cr. | 36,000,000 Shares |
FaceValue | 10 | |
About PSP Projects Ltd. | ||
Over the years, they have successfully executed a number of prestigious projects across Gujarat. One of the first major projects that they completed was the construction of the GCS Medical College, Hospital and Research Centre (managed by the Gujarat Cancer Society) in June 2012. Subsequently, they have successfully executed a number of prestigious projects, including, the construction and interior works of Swarnim Sankul 01 and 02 at Gandhinagar, the construction of the Zydus Hospital at Ahmedabad, and various works in relation to the Sabarmati Riverfront Development project at Ahmedabad. Further, they have completed or are currently undertaking projects for a number of reputed customers. |
1 Day |
|
+3.36% |
1 Week |
|
+0.86% |
1 Month |
|
+7.62% |
3 Month |
|
-5.45% |
6 Month |
|
+9.15% |
1 Year |
|
+21.17% |
2 Year |
|
+63.94% |
5 Year |
|
+99.47% |
10 Year |
|
8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 34.41 | 50.05 | 32.70 | 26.57 | 31.14 | 16.84 | 27.19 | 18.10 | |
Return on Capital Employed (%) | 34.35 | 50.41 | 43.91 | 40.16 | 40.30 | 21.83 | 35.28 | 24.83 | |
Return on Assets (%) | 8.81 | 14.46 | 14.31 | 13.44 | 15.22 | 8.61 | 14.84 | 8.94 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 64 | 105 | 301 | 369 | 454 | 536 | 687 | 801 | 868 | |
Non Curr. Liab. | -1 | 1 | -1 | -6 | -3 | -6 | 7 | 27 | 10 | |
Curr. Liab. | 186 | 219 | 296 | 365 | 504 | 452 | 565 | 924 | 1,188 | |
Minority Int. | 0 | 1 | 1 | 1 | 1 | |||||
Equity & Liab. | 250 | 325 | 597 | 729 | 956 | 982 | 1,259 | 1,752 | 2,066 | |
Non Curr. Assets | 68 | 116 | 172 | 188 | 257 | 289 | 438 | 470 | 497 | |
Curr. Assets | 182 | 207 | 425 | 542 | 699 | 693 | 821 | 1,282 | 1,570 | |
Misc. Exp. not W/O | 2 | |||||||||
Total Assets | 250 | 325 | 597 | 729 | 956 | 982 | 1,259 | 1,752 | 2,066 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 476 | 445 | 752 | 1,050 | 1,499 | 1,241 | 1,748 | 1,938 | 2,363 | |
Other Income | 10 | 13 | 19 | 23 | 24 | 17 | 22 | 25 | 25 | |
Total Income | 486 | 458 | 770 | 1,073 | 1,523 | 1,258 | 1,770 | 1,963 | 2,388 | |
Total Expenditure | -441 | -378 | -647 | -902 | -1,308 | -1,106 | -1,490 | -1,708 | -2,082 | |
PBIDT | 45 | 81 | 123 | 171 | 215 | 152 | 280 | 255 | 306 | |
Interest | -3 | -8 | -9 | -10 | -15 | -15 | -26 | -32 | -41 | |
Depreciation | -7 | -8 | -11 | -24 | -27 | -26 | -32 | -40 | -48 | |
Taxation | -13 | -23 | -36 | -48 | -45 | -28 | -55 | -48 | -57 | |
Exceptional Items | ||||||||||
PAT | 22 | 42 | 66 | 89 | 128 | 83 | 166 | 135 | 160 | |
Minority Interest | 1 | 0 | 0 | 0 | 0 | 1 | ||||
Share Associate | 0 | 0 | -2 | 0 | -3 | -3 | ||||
Other Related Items | ||||||||||
Consolidated Net Profit | 23 | 42 | 66 | 89 | 128 | 82 | 167 | 132 | 158 | |
Adjusted EPS | 71 | 14 | 18 | 25 | 36 | 23 | 46 | 37 | 44 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 40 | -8 | 70 | 21 | 16 | 73 | 147 | 45 | |
Cash Fr. Inv. | -45 | -4 | -122 | -23 | -8 | 5 | -164 | -51 | |
Cash Fr. Finan. | 6 | 22 | 81 | -26 | -2 | -4 | -11 | 12 | |
Net Change | 1 | 11 | 29 | -27 | 6 | 74 | -28 | 6 | |
Cash & Cash Eqvt | 22 | 34 | 63 | 36 | 41 | 116 | 88 | 94 |
Fri, 24 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Thu, 09 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Wed, 08 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
Fri, 01 Dec 2023 |
|
|
|
|
|